MHRA: MLX 357 - Outcome of consultation on measures to strengthen the medicines’ supply chain and reduce risk from counterfeit medicines

This consultation sought your views on a number of proposals to improve the operation of the medicines’ supply chain in the UK. It also sought views on European Commission proposals to amend Directive 2001/83/EC with the aim of reducing the risk of counterfeit medicines entering the legitimate supply chain in Europe.